AstraZeneca Is Said to Have Explored Bristol Myers Merger
Summary
AstraZeneca has explored acquiring Bristol Myers Squibb, according to people familiar with the matter. The potential transaction would be the largest merger in the pharmaceutical industry.
The talks, if pursued, would signal that scale and pipeline depth are driving another wave
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A deal of this size could reset pharmaceutical industry valuations and concentrate power over major drug pipelines.